FILING ANALYSIS · THURSDAY, NOVEMBER 5
Apyx Medical Corp APYX — 8-K: Results of Operations and Financial Condition
neutral
Apyx Medical Corp reported a 17% growth in Surgical Aesthetics revenue and a 9% increase in total revenue for the third quarter, with reaffirmed total revenue guidance for FY2026, but the OEM revenue decreased by 42%
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →